The NEDD8-activating enzyme inhibitor MLN4924 reduces ischemic brain injury in mice

Huilin Yu,Haiyu Luo,Luping Chang,Shisheng Wang,Xue Geng,Lijing Kang,Yi Zhong,Yongliang Cao,Ranran Wang,Xing Yang,Yuanbo Zhu,Mei-Juan Shi,Yue Hu,Zhongwang Liu,Xuhui Yin,Yunwei Ran,Hao Yang,Wenying Fan,Bing-Qiao Zhao
DOI: https://doi.org/10.1073/pnas.2111896119
IF: 11.1
2022-01-31
Proceedings of the National Academy of Sciences
Abstract:Significance Ischemic stroke is a leading cause of death and disability with limited therapies. Neuronal precursor cell-expressed developmentally downregulated protein 8 (NEDD8) is a ubiquitin-like protein that is involved in protein neddylation. The first-in-class anticancer agent called MLN4924 plays a crucial role in suppressing tumorigenesis and attenuating inflammatory responses due to specifically inhibiting NEDD8-activating enzyme. Here, we investigated the potential protective role of MLN4924 after experimental stroke. We showed that the neddylation pathway is overactivated in the brain following cerebral ischemia. Inhibition of neddylation by MLN4924 protects the brain against ischemic injury by attenuating neutrophil extravasation and maintaining blood–brain barrier integrity. Our findings provide insights into the promising treatment with neddylation inhibition for ischemic brain injury.
multidisciplinary sciences
What problem does this paper attempt to address?